You are here: Home / Infrastructures / Res. Infrastructure
European Research Infrastructure for Translational Medicine (EATRIS ERIC)
Identification
Hosting Legal Entity
Self-standing RI
Legal Status
ERIC
Location
De Boelelaan 1118, Amsterdam University Medical Centre / Polikliniek, Amsterdam, PO: 1081 (Netherlands)
Structure
Type Of RI
Distributed
Coordinating Country
Netherlands
Participating Countries
Italy
Finland
France
Bulgaria
Netherlands
Luxembourg
Slovenia
Spain
Norway
Sweden
Latvia
Portugal
Czech Republic
Nodes
Provider Country:
Bulgaria
Sofia University
Provider Country:
Czech Republic
University of Olomouc (Institute of Molecular and Translational Medicine)
Provider Country:
Finland
University of Helsinki (Institute for Molecular Medicine)
Provider Country:
France
CEA-NeurATRIS
Provider Country:
Italy
Istitute Superiore di Sanita
Provider Country:
Latvia
Riga Stradins University
Provider Country:
Luxembourg
Integrated Biobank of Luxembourg
Provider Country:
Netherlands
Amsterdam University Medical Centre
Provider Country:
Norway
University of Oslo (Centre for Molecular Medicine)
Provider Country:
Portugal
INFARMED
Provider Country:
Slovenia
University of Ljubljana
Provider Country:
Spain
Vall d'Hebron Research Institute
Provider Country:
Sweden
Uppsala University
Status
Status
Current Status:
Operational since 2013
Scientific Description
EATRIS is a distributed RI that provides a unique one-stop shop access to the combined expertise and high-end technologies, required to develop new products for translational medicine, from target validation to early clinical trials. By selecting several key resources in Europe, users can access to research tools and guidance required for drug development, ranging from state-of-the-art scientific equipment, knowledge-based resources from sample collections to GMP manufacturing and regulatory guidance. Services and access to patient cohorts are provided in the fields of advanced therapy medicinal products, biomarkers, imaging and tracing, small molecules and vaccines.EATRIS received the status of European Research Infrastructure Consortium (ERIC) in November 2013. It comprises 90 leading institutes in 13 countries – 12 Members and 1 Observer – that represent the wide diversity of stakeholders who seek solutions to the many issues arising in the development of new therapies.By bringing together Europe's best institutions in academic translational medicine, EATRIS has created a portfolio of research services focused on predicting the performance of novel products, selecting the right patient, and entering clinical development as safely and effectively as possible. On the basis of a detailed database and knowledge of its growing member institutions, EATRIS quickly matches the users’ needs with the right expertise and facilities to build project teams along technology pipelines and supporting services, running from target/biomarker validation up to clinical proof of concept, covering the following areas: Advanced Therapy Medicinal Products (ATMP) and biologics – including Gene Therapy Medicinal Products (GTMP), Cell Therapy Medicinal Products (CTMP), and Tissue Engineered Products (TEP), represent a new category of medicines with a wide therapeutic potential for treating different types of diseases such as cancer, neurodegenerative and cardiovascular diseases; Small Molecules, to support the pre-clinical and clinical development of drug candidates, utilising academic expertise around novel targets; Vaccines, to cover the entire vaccine development and production pipeline ranging from late-phase pre-clinical development to clinical trials.These pipelines are supported by cutting edge enabling technologies: Imaging and Tracing, to provide a single point of entry to high-end expertise and cutting-edge translational imaging facilities, defragmenting the technical know-how and making optimal use of resources to improve R&D output; Biomarkers for precision medicine, to facilitate the validation and development of biomarkers for the prevention, diagnosis and prognostic assessment of disease as well as for the prediction of therapy response.In order to ensure that each project has a comprehensive team and best chance of success, EATRIS also offers regulatory support, as well as education and training opportunities in translational research.

RI Keywords
Biomarker facilities, Imaging, Preclinical imaging, OMICs, Industry, Drug development, Tracers, Biomarkers, Training, Product development, Translational medicine, Vaccines, Animal models, Clinical trials, Advanced therapy medicinal products, Biomedical translational research, Molecular medicine, Innovation
Classifications
RI Category
Translational Research Centres
Scientific Domain
Biological and Medical Sciences
ESFRI Domain
Health and Food
Services
Regulatory support

Addressing regulatory issues is an integral part of bio medicinal development, and their importance will only continue to increase for the foreseeable future. The EATRIS regulatory service and support centre is available to help guide you through this complex world, especially for complex and hybrid products for which clear regulatory guidance may not be available. Early assessment of the potential requirements may prevent unnecessary project delays, reduce extra costs and most importantly prevent penalties resulting from non-adherence to legal requirements. Through a combination of in-house and external partnerships with a range of regulatory experts and groups, EATRIS can provide regulatory support for most types of product. Our range of services include: - Expert opinion - Orphan Drug Designation and Scientific Advice application at the EMA - Pre-clinical and clinical plan development - Informal scientific advice with selected national competent authorities, for highly complex projects This service is a fee-based service available for academia and industry. Please contact info@eatris.eu for more information.

Equipment
Biomedical laboratory equipment

Biomedical laboratory equipment for the product categories ATMPs, Biomarkers, Imaging and Tracing, Vaccines and Small Molecules.

Collaborations
ESFRI
RI is an ESFRI landmark
Networks
Coordinated Research Infrastructures Building Enduring Life-Science Services (CORBEL)
Date of last update: 16/04/2019
Printable version